RespireRx Pharmaceuticals Inc (RSPI)

[haysaw]

It seems that new mgmnt has developed a prioritized interest in the ampakine platform, ie, respiratory depression. I didn't recognize any prominent interest in past communications. If RD is as novel and reliable as studies have shown, then good management could finally take us to another level, notwithstanding an existing handicap courtesy of the prior pathetic team of Stoll/Varney. They were awful leaders, without question.